ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
1.830
+0.040 (2.23%)
Mar 25, 2026, 4:00 PM EDT - Market closed
ProKidney Market Cap
ProKidney has a market cap or net worth of $259.76 million as of March 25, 2026. Its market cap has decreased by -14.78% in one year.
Market Cap
259.76M
Enterprise Value
-6.23M
1-Year Change
-14.78%
Ranking
Category
Stock Price
$1.83
Market Cap Chart
Since June 30, 2021, ProKidney's market cap has increased from $258.80M to $259.76M, an increase of 0.37%. That is a compound annual growth rate of 0.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 552.50M | -18.01% |
| Dec 31, 2025 | 673.90M | 36.72% |
| Dec 31, 2024 | 492.90M | 17.61% |
| Dec 29, 2023 | 419.10M | -73.75% |
| Dec 30, 2022 | 1.60B | 405.76% |
| Dec 31, 2021 | 315.70M | 21.99% |
| Jun 30, 2021 | 258.80M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orchestra BioMed Holdings | 272.71M |
| Protara Therapeutics | 270.96M |
| ALX Oncology Holdings | 268.48M |
| Minerva Neurosciences | 261.38M |
| Rezolute | 257.43M |
| Coherus Oncology | 256.31M |
| Abeona Therapeutics | 247.02M |
| Silence Therapeutics | 245.62M |